Prudential Financial Inc Biohaven Pharmaceutical Holding CO Ltd. Transaction History

Prudential Financial Inc

$65.9 Billion
Q2 2024

17 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2022 Nov 04, 2022	SELL	$144.95 - $152.29 $129,730 - $136,299	-895 Reduced 16.56%	4,511 $684,000
Q2 2022 Aug 15, 2022	SELL	$83.14 - $145.99 $14,466 - $25,402	-174 Reduced 3.12%	5,406 $788,000
Q1 2022 May 13, 2022	BUY	$110.08 - $142.92 $123,509 - $160,356	1,122 Added 25.17%	5,580 $662,000
Q4 2021 Feb 14, 2022	SELL	$99.73 - $148.48 $1.33 Million - $1.98 Million	-13,353 Reduced 74.97%	4,458 $660,000
Q3 2021 Nov 15, 2021	BUY	$98.85 - $138.91 $1.32 Million - $1.85 Million	13,315 Added 296.15%	17,811 $2.47 Million
Q2 2021 Aug 16, 2021	BUY	$65.78 - $105.02 $23,023 - $36,757	350 Added 8.44%	4,496 $437,000
Q1 2021 May 12, 2021	BUY	$64.07 - $91.75 $4,933 - $7,064	77 Added 1.89%	4,146 $283,000
Q4 2020 Feb 16, 2021	BUY	$65.07 - $98.24 $206,336 - $311,519	3,171 Added 353.12%	4,069 $349,000
Q3 2020 Aug 05, 2021	SELL	$59.04 - $77.95 $130,891 - $172,815	-2,217 Reduced 71.17%	898 $58,000
Q3 2020 Nov 16, 2020	BUY	$59.04 - $77.95 $175,112 - $231,199	2,966 Added 1990.6%	3,115 $203,000
Q2 2020 Aug 05, 2021	SELL	$29.01 - $74.23 $82,272 - $210,516	-2,836 Reduced 95.01%	149 $11,000
Q2 2020 Aug 12, 2020	BUY	$29.01 - $74.23 $86,594 - $221,576	2,985 New	2,985 $218,000
Q4 2019 Feb 11, 2020	SELL	$40.86 - $57.65 $18,305 - $25,827	-448 Closed	0 $0
Q3 2019 Aug 05, 2021	SELL	$37.38 - $49.47 $870,654 - $1.15 Million	-23,292 Reduced 98.11%	448 $19,000
Q3 2019 Nov 13, 2019	BUY	$37.38 - $49.47 $866,206 - $1.15 Million	23,173 Added 4086.95%	23,740 $990,000
Q2 2019 Aug 05, 2021	SELL	$39.79 - $67.01 $3.27 Million - $5.5 Million	-82,083 Reduced 99.31%	567 $25,000
Q2 2019 Aug 08, 2019	BUY	$39.79 - $67.01 $3.29 Million - $5.54 Million	82,650 New	82,650 $0

Others Institutions Holding BHVN

# of Institutions

Shares Held

785K

Call Options Held

Put Options Held

View Full List

About Biohaven Pharmaceutical Holding Co Ltd.

Ticker BHVN
Exchange NYSE
Sector Healthcare
Industry Biotechnology
Shares Outstandng 71,645,000
Market Cap $3.65B
Description
Biohaven Pharmaceutical Holding Company Ltd., a biopharmaceutical company, develops products candidates targeting neurological and neuropsychiatric diseases, and rare disorders in the United States. It offers NURTEC ODT (rimegepant) for the acute treatment of migraine, as well as developing Rimegepant for preventive treatment of migraine; Zavege...

More about BHVN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Prudential Financial Inc, based on Form 13F filings with the SEC.

News

Stay updated on Prudential Financial Inc with notifications on news.

Account